Shares of Disc Medicine Inc. (NASDAQ:IRON) were trading at $56.94, up $9.81, or 20%, after the firm disclosed positive feedback from its end-of-phase II meeting with the FDA, supporting the regulatory ...
(HealthDay News) — Hormone replacement therapy (HRT) is associated with an increased risk for developing irritable bowel syndrome (IBS) in postmenopausal women, according to a study presented at the ...
A second physician in Texas is facing a lawsuit from Attorney General Ken Paxton for allegedly violating state law by prescribing puberty blockers and hormone therapy drugs to minors.
There is no statutory bar in the US for patenting drug-device combinations, including drug transdermal/thermal patches. In the US, patents for methods of treatment are also allowed. A list of a few ...